Advertisement

HCV-Negative Mixed Cryoglobulinemia: Facts and Fancies

  • Massimo Galli
  • Salvatore Sollima
  • Giuseppe Monti
Chapter

Abstract

Approximately 10% of the population with mixed cryoglobulinemia (MC) have no evidence of HCV infection. In these patients, a wide number of infectious agents have been associated with cryoglobulinemia, although only HBV and HIV have a well- documented role in causing the disorder. Several connective tissue (mainly systemic lupus erythematosus, Sjögren’s syndrome, and systemic sclerosis) and lymphoproliferative (in most cases B-cell non-Hodgkin lymphoma) diseases have also been shown to play an etiologic role in some cases of HCV-negative MC. Fewer than 5% of cryoglobulinemic patients show no identifiable underlying diseases and they are therefore considered as having “essential” MC. In HCV-negative MC, an occult HCV infection should also be taken into account. The clinical manifestations, cryoglobulin levels, and survival rates in MC patients with and without HCV seem not to differ significantly, although the data are conflicting. In symptomatic MC, therapy should aim at improvement or resolution of clinical manifestations, as elimination of the causative factor is impossible in most cases.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Mixed Cryoglobulinemia Mixed Cryoglobulinemia Patient Cryoglobulin Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569–570PubMedCrossRefGoogle Scholar
  2. 2.
    Casato M, TaIiani G, Pucillo LP et al (1991) Cryoglo­bulinaemia and epatitis C virus. Lancet 337:1047–1048PubMedCrossRefGoogle Scholar
  3. 3.
    Ferri C, Greco F, Longombardo G et al (1991) Association between hepatitis C virus and mixed cryoglobulinaemia. Clin Exp Rheumatol 9:621–624PubMedGoogle Scholar
  4. 4.
    Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490–1495PubMedCrossRefGoogle Scholar
  5. 5.
    Misiani R, Bellavita P, Fenili D et al (1992) Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573–577PubMedCrossRefGoogle Scholar
  6. 6.
    Lunel F, Musset L, Cacoub P et al (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300PubMedGoogle Scholar
  7. 7.
    Monti G, Galli M, Invenizzi F et al (1995) Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 88:115–126PubMedGoogle Scholar
  8. 8.
    Dammacco F, Sansonno D, Piccoli C et al (2001) The cryoglobulins: an overview. Eur J Clin Invest 31:628–638PubMedCrossRefGoogle Scholar
  9. 9.
    Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355–374PubMedCrossRefGoogle Scholar
  10. 10.
    Saadoun D, Sellam J, Ghillani-Dalbin P et al (2006) Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166:2101–2108PubMedCrossRefGoogle Scholar
  11. 11.
    Weiner SM, Berg T, Berthold H et al (1998) A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 29:375–384PubMedCrossRefGoogle Scholar
  12. 12.
    Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54–63PubMedGoogle Scholar
  13. 13.
    Gorevic PD, Kassab HJ, Levo Y et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287–308PubMedCrossRefGoogle Scholar
  14. 14.
    Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42:2507–2516PubMedCrossRefGoogle Scholar
  15. 15.
    Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins. J Clin Pathol 55:4–13PubMedCrossRefGoogle Scholar
  16. 16.
    Granel B, Serratrice J, Morange PE et al (2004) Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-Guerin. Clin Exp Rheumatol 22:481–482PubMedGoogle Scholar
  17. 17.
    Hermida Lazcano I, Saez Méndez L, Solera Santos J (2005) Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis. J Infect 51:e257–e259PubMedCrossRefGoogle Scholar
  18. 18.
    Trendelenburg M, Schifferli JA (1998) Cryoglobulins are not essential. Ann Rheum Dis 57:3–5PubMedCrossRefGoogle Scholar
  19. 19.
    Galli M, Invernizzi F, Chemotti M et al (1986) Cryoglobulins and infectious diseases. Ric Clin Lab 16:301–313PubMedGoogle Scholar
  20. 20.
    Galli M (1995) Viruses and cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S63–S70PubMedGoogle Scholar
  21. 21.
    Iori GP, Buonanno G (1972) Chronic hepatitis and cirrhosis of the liver in cryoglobulinemia. Gut 13:610–613CrossRefGoogle Scholar
  22. 22.
    Florin-Christensen A, Roux MEB, Arana RM (1974) Cryoglobulins in acute and chronic liver diseases. Clin Exp Immunol 16:599–605PubMedGoogle Scholar
  23. 23.
    Levo Y, Gorevic PD, Kassab HJ et al (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296:1501–1504PubMedCrossRefGoogle Scholar
  24. 24.
    Dienstag JL, Wands JR, Isselbacher KJ (1977) Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med 297:946–947PubMedGoogle Scholar
  25. 25.
    Popp JW Jr, Dienstag JL, Wands JR, Bloch KJ (1980) Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 92:379–383PubMedCrossRefGoogle Scholar
  26. 26.
    Galli M (1991) Cryoglobulinaemia and serological markers of hepatitis viruses. Lancet 338:758–759PubMedCrossRefGoogle Scholar
  27. 27.
    Galli M, Monti G, Invernizzi F et al (1992) Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicenter study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC). Ann Ital Med Int 7:209–214PubMedGoogle Scholar
  28. 28.
    Ferri C (2008) Mixed cryoglobulinernia. Orphan J Rare Dis 3:25CrossRefGoogle Scholar
  29. 29.
    Cohen P, Roulot D, Ferrière F et al (1997) Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. Clin Exp Rheumatol 15:523–527PubMedGoogle Scholar
  30. 30.
    Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM (1999) Mixed cryoglobulinemia in HIV-l infection: the role of HIV-1. Ann Intem Med 130:226–230CrossRefGoogle Scholar
  31. 31.
    Fabris P, Tositti G, Giordani MT et al (2003) Prevalence and clinical significance of circulating cryoglobulins in HIV -positive patients with and without co-infection with hepatitis C virus. J Med Virol 69:339–343PubMedCrossRefGoogle Scholar
  32. 32.
    Scotto G, Cibelli DC, Saracino A et al (2006) Cryoglo­bulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection. J Infect 52:294–299PubMedCrossRefGoogle Scholar
  33. 33.
    Kosmas N, Kontos A, Panayiotakopoulos G et al (2006) Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV -positive, HCV-negative patients. J Med Virol 78:1257–1261PubMedCrossRefGoogle Scholar
  34. 34.
    Antinori S, Galimberti L, Rusconi S et al (1995) Disap­pea­rance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 13(Suppl 13):S157–S159PubMedGoogle Scholar
  35. 35.
    Palacios R, Santos J, Valdivielso P, Marquez M (2002) Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 11:60–63PubMedCrossRefGoogle Scholar
  36. 36.
    Trejo O, Ramos-Casals M, Garcia-Carrasco M et al (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single centre. Medicine (Baltimore) 80:252–262CrossRefGoogle Scholar
  37. 37.
    Mascia MT, Ferrari D, Campioli D et al (2007) Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 39(Suppl l):S61–S64PubMedCrossRefGoogle Scholar
  38. 38.
    Rieu V, Cohen P, André MH et al (2002) Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41:290–300CrossRefGoogle Scholar
  39. 39.
    Cacoub P, Fabiani FL, Musset L et al (1994) Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96:124–132PubMedCrossRefGoogle Scholar
  40. 40.
    Tarantino A, Campise M, Banfi G et al (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47:618–623PubMedCrossRefGoogle Scholar
  41. 41.
    Della Rossa A, Marchi F, Catarsi E et al (2008) Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol 26(Suppl 51):S105–S108PubMedGoogle Scholar
  42. 42.
    Castillo I, Pardo M, Bartolomé J et al (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver function tests is unknown. J Infect Dis 189:7–14PubMedCrossRefGoogle Scholar
  43. 43.
    Casato M, Lilli D, Donato G et al (2003) Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J ViraI Hepat 10:455–459CrossRefGoogle Scholar
  44. 44.
    Ferri C, Moriconi L, Gremignai G et al (1986) Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 43:246–253PubMedCrossRefGoogle Scholar
  45. 45.
    Ferri C, Pietrogrande M, Cecchetti C et al (1989) Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med 87:519–524PubMedCrossRefGoogle Scholar
  46. 46.
    Monti G, Saccardo F, Rinaldi G et al (1995) Colchicine in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S197–S199PubMedGoogle Scholar
  47. 47.
    Tavoni A, Mosca M, Ferri C et al (1995) Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S191–S195PubMedGoogle Scholar
  48. 48.
    Zaja F, De Vita S, Mazzaro C et al (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827–3834PubMedCrossRefGoogle Scholar
  49. 49.
    Sansonno D, De Re V, Lauletta G, et al (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818–3826PubMedCrossRefGoogle Scholar
  50. 50.
    Roccatello D, Baldovino S, Rossi D et al (2004) Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19:3054–3061PubMedCrossRefGoogle Scholar
  51. 51.
    Cacoub P, Delluc A, Saadoun D et al (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis 67:283–287PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Massimo Galli
    • 1
  • Salvatore Sollima
    • 1
  • Giuseppe Monti
    • 2
  1. 1.Department of Clinical Sciences “Luigi Sacco”, Section of Infectious and Tropical DiseasesUniversità di MilanoMilanItaly
  2. 2.Internal Medicine UnitOspedale di SaronnoSaronnoItaly

Personalised recommendations